Ultiva 72078-0035-02
Generic: Remifentanil Hydrochloride
- Manufacturer
- Mylan Institutional Llc
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- September 18, 2023
- Listing Expires
- December 31, 2026
- Application
- NDA020630
Active Ingredients
| Ingredient | Strength |
|---|---|
| Remifentanil Hydrochloride | 1 mg/mL |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Selected Package
72078-0035-02Selected10 VIAL, GLASS in 1 CARTON (72078-035-02) / 5 mL in 1 VIAL, GLASS (72078-035-00)